-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, MH0FrHKttXXDYkFGKnnnTGL/LlNFc7P5TwyJN4R9gHtdKcKoGkMArnGwU2sp/bHc zDoytfexSoMnqOFZMs+Otw== 0000950103-04-000446.txt : 20040326 0000950103-04-000446.hdr.sgml : 20040326 20040326124658 ACCESSION NUMBER: 0000950103-04-000446 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20040324 FILED AS OF DATE: 20040326 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: GENENTECH INC CENTRAL INDEX KEY: 0000318771 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 942347624 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1 DNA WAY CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650-225-1000 MAIL ADDRESS: STREET 1: 1 DNA WAY STREET 2: . CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ROCHE HOLDINGS INC CENTRAL INDEX KEY: 0000904566 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-09813 FILM NUMBER: 04691979 BUSINESS ADDRESS: STREET 1: 1201 NORTH ORANGE STREET STREET 2: SUITE #1050 CITY: WILMINGTON STATE: DE ZIP: 19801-1184 BUSINESS PHONE: 302 425 4701 MAIL ADDRESS: STREET 1: 1201 NORTH ORANGE STREET STREET 2: SUITE #1050 CITY: WILMINGTON STATE: DE ZIP: 19801-1184 4 1 mar2604_form4ex.xml X0201 4 2004-03-24 0 0000318771 GENENTECH INC DNA 0000904566 ROCHE HOLDINGS INC 1201 NORTH ORANGE STREET WILMINGTON DE 19801 0 0 1 0 Common Stock 2004-03-24 4 C 0 8653 0 D 299083923 D Common Stock 2004-03-25 4 C 0 43265 0 D 299040658 D Liquid Yield Option Notes 0 2004-03-24 4 C 0 0 0 D 2000-01-19 2015-01-19 Common Stock 8.653 638309000 D Liquid Yield Option Notes 0 2004-03-25 4 C 0 0 0 D 2000-01-19 2015-01-19 Common Stock 8.653 633309000 D Each $1,000 principal amount of Liquid Yield Option (TM) Notes is exchangeable into 8.65316 shares. On 03/24/2004, the reporting person settled $1,000,000 in principal amount of Liquid Yield Option (TM) Notes. In settlement of such notes, the reporting person delivered 8,653 Genentech shares and $16.13 to the holder of such notes. Issue date In dollar amounts On 03/25/2004, the reporting person settled $5,000,000 in principal amount of Liquid Yield Option (TM) Notes. In settlement of such notes, the reporting person delivered 43,265 Genentech shares and $82.30 to the holders of such notes. /s/ Carol Fiederlein, Vice President, Tax and Accounting and Corporate Secretary 2004-03-26 -----END PRIVACY-ENHANCED MESSAGE-----